JPMorgan Starts Sagent Pharmaceuticals (SGNT) at Neutral
Tweet
Share
E-mailGet Alerts SGNT Hot Sheet
Price: $21.76 --0%
Rating Summary:
1 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 17
Rating Summary:
1 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 17
Join SI Premium – FREE
JPMorgan initiates coverage on Sagent Pharmaceuticals (NASDAQ: SGNT) with a Neutral. PT $25.00.
For more ratings news on Sagent Pharmaceuticals click here and for the rating history of Sagent Pharmaceuticals click here.
Shares of Sagent Pharmaceuticals closed at $20.96 yesterday.
For more ratings news on Sagent Pharmaceuticals click here and for the rating history of Sagent Pharmaceuticals click here.
Shares of Sagent Pharmaceuticals closed at $20.96 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Resumes Drax Group Plc. (DRX:LN) (DRXGY) at Overweight
- Kepler Cheuvreux Starts Jet2 plc (JET2:LN) (DRTGF) at Buy
- BMO Capital Starts Skyworks Solutions (SWKS) at Market Perform
Create E-mail Alert Related Categories
New CoverageRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
